𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2 b

✍ Scribed by Freund, M. ;Wussow, P. ;Kn�ver-Hopf, J. ;Mohr, H. ;Pohl, U. ;Exeriede, G. ;Link, H. ;Wilke, H. J. ;Poliwoda, H.

Publisher
Springer-Verlag
Year
1988
Weight
437 KB
Volume
57
Category
Article
ISSN
1432-0584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-alpha antibodies in patients
Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial
✍ Otto Prümmer; Delta-P Study Group 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 657 KB

Background. Prolonged therapy with interferon (IFN) may lead to the formation of IFN antibodies. Methods. Patients with renal cell carcinoma (n = 270) with advanced localized disease were randomized after complete tumor resection to receive treatment with adjuvant recombinant IFN-alpha-2a (rIFN-a2a

Treatment with human gamma interferon of
Treatment with human gamma interferon of chronic hepatitis B: Comparative study with alpha interferon
✍ Shinichi Kakumu; Tetsuya Ishikawa; Masashi Mizokanii; Etsuro Orido; Kentaro Yosh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 538 KB

## Abstract A pilot study was designed to determine the tolerance and effectiveness of natural or recombinant gamma interferon in patients with chronic hepatitis B. Sixteen patients received 0.5 to 3.0 million units (MU) per day of gamma interferon (IFN‐γ) for 7 days. Nineteen chronic hepatitis B p

Therapy of chronic hepatitis b with reco
Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon
✍ Adrian M. Di Bisceglie; Vinod K. Rustgi; Chris Kassianides; Mauricio Lisker-Melm 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB

Eight patients with chronic hepatitis B entered a pilot study of gamma interferon and alpha interferon in combination. Gamma interferon alone had minimal inhibitory effects on serum levels of hepatitis B virus as monitored by serum HBV DNA and DNA-polymerase activity. The drug also gave troublesome

Treatment of patients with disseminated
Treatment of patients with disseminated colorectal cancer with recombinant human alpha2-interferon. Studies on the immune system
✍ Stefan Einhorn; Jerzy Wasserman; Göran Lundell; Henric Blomgren; Björn Cedermark 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 606 KB

The influence of recombinant human alpha 2-interferon (alpha 2-IFN) therapy on various aspects of the immune system was studied in 18 patients with disseminated colorectal cancer. The IFN was given as continuous (20 X 10(6) units/m2 three times weekly) or intermittent (50 X 10(6) units/m2 daily for